ITCI: Intra-Cellular Therapies Inc. Stocks News on December 27, 2024

Intra-Cellular Therapies Presents Data from the CAPLYTA Adjunctive MDD Phase 3 Program at the American College of Neuropsychopharmacology Annual Meeting

ITCI

GlobeNewswire

16 days ago

Intra-Cellular Therapies Presents Data from the CAPLYTA Adjunctive MDD Phase 3 Program at the American College of Neuropsychopharmacology Annual Meeting

ITCI

Zacks

23 days ago

ITCI Submits sNDA to the FDA for Expanded Use of Caplyta in MDD

ITCI

MT Newswires

24 days ago

Intra-Cellular Therapies Files Supplemental NDA for Caplyta as Adjunctive Treatment for Major Depressive Disorder

Intra-Cellular Therapies Submits Supplemental New Drug Application (sNDA) to FDA for CAPLYTA® (lumateperone) for the Treatment of Major Depressive Disorder as Adjunctive Therapy

ITCI

GlobeNewswire

24 days ago

Intra-Cellular Therapies Submits Supplemental New Drug Application (sNDA) to FDA for CAPLYTA® (lumateperone) for the Treatment of Major Depressive Disorder as Adjunctive Therapy

ITCI

Zacks

a month ago

Why Is Intra-Cellular (ITCI) Up 2.2% Since Last Earnings Report?

How Intra-Cellular surprised Wall Street by breaking character

ITCI

BioPharma Dive

a month ago

How Intra-Cellular surprised Wall Street by breaking character

ITCI

MT Newswires

a month ago

UBS Raises Price Target on Intra-Cellular Therapies to $87 From $79, Maintains Neutral Rating

Intra-Cellular Therapies to Participate in Three Upcoming Investor Conferences

ITCI

GlobeNewswire

a month ago

Intra-Cellular Therapies to Participate in Three Upcoming Investor Conferences

ITCI

MT Newswires

a month ago

Intra-Cellular Therapies Insider Sold Shares Worth $3,692,100, According to a Recent SEC Filing

Intra-Cellular Therapies Announces Presentations at the 2024 Psych Congress and NEI Congress

ITCI

GlobeNewswire

2 months ago

Intra-Cellular Therapies Announces Presentations at the 2024 Psych Congress and NEI Congress

Intra-Cellular bolsters Caplyta data with another Phase III win

ITCI

Pharmaceutical Technology

2 months ago

Intra-Cellular bolsters Caplyta data with another Phase III win

ITCI

Clinical Trials Arena

2 months ago

Intra-Cellular bolsters Caplyta data with another Phase III win

Intra-Cellular Therapies Announces Positive Topline Results in Phase 3 Trial Evaluating CAPLYTA for the Prevention of Relapse in Patients with Schizophrenia

ITCI

GlobeNewswire

2 months ago

Intra-Cellular Therapies Announces Positive Topline Results in Phase 3 Trial Evaluating CAPLYTA for the Prevention of Relapse in Patients with Schizophrenia

ITCI

Simply Wall St.

2 months ago

Here's What Analysts Are Forecasting For Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) After Its Third-Quarter Results

Intra-Cellular Therapies Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

ITCI

Simply Wall St.

2 months ago

Intra-Cellular Therapies Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

ITCI

GuruFocus.com

2 months ago

Intra-Cellular Therapies Inc (ITCI) Q3 2024 Earnings Call Highlights: Robust Sales Growth and ...

ITCI

Zacks

2 months ago

ITCI Q3 Loss Wider Than Expected, Revenues Top on Higher Caplyta Sales

ITCI

Zacks

2 months ago

Intra-Cellular Therapies (ITCI) Reports Q3 Loss, Tops Revenue Estimates

ITCI

MT Newswires

2 months ago

Intra-Cellular Therapies Posts Unchanged Q3 Net Loss, Revenue Rises

ITCI

Associated Press Finance

2 months ago

Intra-Cellular: Q3 Earnings Snapshot

Intra-Cellular Therapies Reports Third Quarter 2024 Financial Results, Provides Corporate Update and Raises 2024 Caplyta Sales Guidance

ITCI

GlobeNewswire

2 months ago

Intra-Cellular Therapies Reports Third Quarter 2024 Financial Results, Provides Corporate Update and Raises 2024 Caplyta Sales Guidance

ITCI

GuruFocus.com

2 months ago

What To Expect From Intra-Cellular Therapies Inc (ITCI) Q3 2024 Earnings

ITCI

Zacks

2 months ago

Intra-Cellular Therapies (ITCI) Expected to Beat Earnings Estimates: Should You Buy?

Intra-Cellular Therapies to Host Third Quarter 2024 Financial Results Conference Call and Webcast

ITCI

GlobeNewswire

2 months ago

Intra-Cellular Therapies to Host Third Quarter 2024 Financial Results Conference Call and Webcast

ITCI

Insider Monkey

2 months ago

Intra-Cellular Therapies, Inc. (ITCI): Among the Most Promising Mid-Cap Stocks According to Hedge Funds

Intra-Cellular's Caplyta Sales Boost Revenues, Dependence a Woe

ITCI

Zacks

3 months ago

Intra-Cellular's Caplyta Sales Boost Revenues, Dependence a Woe

ITCI

MT Newswires

3 months ago

Morgan Stanley Raises Price Target on Intra-Cellular Therapies to $95 From $92, Keeps Overweight Rating

JPMorgan Chase & Co's Strategic Acquisition of Shares in Intra-Cellular Therapies Inc

ITCI

GuruFocus.com

3 months ago

JPMorgan Chase & Co's Strategic Acquisition of Shares in Intra-Cellular Therapies Inc

ITCI

MT Newswires

3 months ago

RBC Lifts Price Target on Intra-Cellular Therapies to $108 From $106, Keeps Outperform Rating

Intra-Cellular Therapies Announces Presentations at the 2024 European College of Neuropsychopharmacology Congress

ITCI

GlobeNewswire

3 months ago

Intra-Cellular Therapies Announces Presentations at the 2024 European College of Neuropsychopharmacology Congress

ITCI

Simply Wall St.

3 months ago

Intra-Cellular Therapies (NASDAQ:ITCI) delivers shareholders fantastic 54% CAGR over 5 years, surging 3.9% in the last week alone

ITCI

Zacks

4 months ago

Why Is Intra-Cellular (ITCI) Down 2.7% Since Last Earnings Report?

ITCI

MT Newswires

4 months ago

Piper Sandler Upgrades Intra-Cellular Therapies to Overweight From Neutral, $92 Price Target

ITCI

Insider Monkey

4 months ago

Intra-Cellular Therapies, Inc. (ITCI): Among the Best Mid-Cap Healthcare Stocks To Buy Now

ITCI

MT Newswires

4 months ago

Intra-Cellular Therapies Insider Sold Shares Worth $5,089,236, According to a Recent SEC Filing

Intra-Cellular Therapies to Present at Three Upcoming Investor Conferences

ITCI

GlobeNewswire

4 months ago

Intra-Cellular Therapies to Present at Three Upcoming Investor Conferences

ITCI

MT Newswires

4 months ago

Intra-Cellular Therapies Insider Sold Shares Worth $9,086,738, According to a Recent SEC Filing

ITCI

Simply Wall St.

4 months ago

Here's Why We're Not At All Concerned With Intra-Cellular Therapies' (NASDAQ:ITCI) Cash Burn Situation

Biotech Stock Pulls Back After Earnings Report; Profits On The Horizon

ITCI

Investor's Business Daily

5 months ago

Biotech Stock Pulls Back After Earnings Report; Profits On The Horizon

ITCI

MT Newswires

5 months ago

UBS Adjusts Price Target on Intra-Cellular Therapies to $79 From $83, Maintains Neutral Rating

ITCI

Zacks

5 months ago

Intra-Cellular (ITCI) Q2 Loss Narrower Than Expected, Sales Beat

Intra-Cellular Therapies to Present at the Canaccord Genuity 44th Annual Growth Conference

ITCI

GlobeNewswire

5 months ago

Intra-Cellular Therapies to Present at the Canaccord Genuity 44th Annual Growth Conference

ITCI

MT Newswires

5 months ago

RBC Trims Price Target on Intra-Cellular Therapies to $106 From $107, Keeps Outperform Rating

Biotech Stocks: Why Acadia Pharma And Others Are Feeling 'Growing Pains'

ITCI

Investor's Business Daily

5 months ago

Biotech Stocks: Why Acadia Pharma And Others Are Feeling 'Growing Pains'

ITCI

MT Newswires

5 months ago

Intra-Cellular Therapies Appoints Sanjeev Narula CFO

ITCI

Zacks

5 months ago

Intra-Cellular Therapies (ITCI) Reports Q2 Loss, Tops Revenue Estimates

ITCI

MT Newswires

5 months ago

Intra-Cellular Therapies Q2 Net Loss Narrows, Revenue Rises

ITCI

Associated Press Finance

5 months ago

Intra-Cellular: Q2 Earnings Snapshot

Intra-Cellular Therapies Announces Appointment of Sanjeev Narula as Chief Financial Officer

ITCI

GlobeNewswire

5 months ago

Intra-Cellular Therapies Announces Appointment of Sanjeev Narula as Chief Financial Officer

Intra-Cellular Therapies Reports Second Quarter 2024 Financial Results, Provides Corporate Update and Raises 2024 CAPLYTA Sales Guidance

ITCI

GlobeNewswire

5 months ago

Intra-Cellular Therapies Reports Second Quarter 2024 Financial Results, Provides Corporate Update and Raises 2024 CAPLYTA Sales Guidance

Arcus Biosciences, Inc. (RCUS) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release

ITCI

Zacks

5 months ago

Arcus Biosciences, Inc. (RCUS) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release

ITCI

Zacks

5 months ago

Intra-Cellular Therapies (ITCI) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Intra-Cellular Therapies to Host Second Quarter 2024 Financial Results Conference Call and Webcast

ITCI

GlobeNewswire

5 months ago

Intra-Cellular Therapies to Host Second Quarter 2024 Financial Results Conference Call and Webcast

ITCI

MT Newswires

5 months ago

Needham Adjusts Intra-Cellular Therapies Price Target to $100 From $94, Maintains Buy Rating

ITCI

Simply Wall St.

5 months ago

Analysts Expect Breakeven For Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) Before Long

ITCI

Zacks

6 months ago

Wall Street Analysts See a 30.14% Upside in Intra-Cellular (ITCI): Can the Stock Really Move This High?

ITCI

MT Newswires

6 months ago

RBC Raises Price Target on Intra-Cellular Therapies to $107 From $103, Keeps Outperform Rating

ITCI

Zacks

6 months ago

Intra-Cellular's (ITCI) Caplyta Boosts Sales, Dependence a Woe

Intra-Cellular Therapies Stock Scores RS Rating Upgrade To 87

ITCI

Investor's Business Daily

6 months ago

Intra-Cellular Therapies Stock Scores RS Rating Upgrade To 87

ITCI

MT Newswires

6 months ago

Needham Adjusts Intra-Cellular Therapies Price Target to $94 From $90, Maintains Buy Rating

ITCI

MT Newswires

6 months ago

RBC Capital Adjusts Intra-Cellular Therapies Price Target to $103 From $96, Maintains Outperform Rating

ITCI

MT Newswires

6 months ago

Goldman Sachs Adjusts Intra-Cellular Therapies Price Target to $77 From $76, Maintains Neutral Rating

ITCI

MT Newswires

6 months ago

Mizuho Securities Adjusts Intra-Cellular Therapies Price Target to $100 From $96, Maintains Buy Rating

ITCI

MT Newswires

6 months ago

Canaccord Genuity Adjusts Intra-Cellular Therapies Price Target to $113 From $107, Maintains Buy Rating

ITCI

Zacks

6 months ago

Biotech Stock Roundup: ITCI Up on Study Data, ZNTL, OVID Down on Updates & More News

ITCI

Zacks

6 months ago

Intra-Cellular (ITCI) Up as Second Depression Study Meets Goals

ITCI

Zacks

6 months ago

Intra-Cellular (ITCI) Soars 9.6%: Is Further Upside Left in the Stock?

Intra-Cellular Therapies edges closer to FDA win for Caplyta in depression

ITCI

Clinical Trials Arena

6 months ago

Intra-Cellular Therapies edges closer to FDA win for Caplyta in depression

Intra-Cellular Therapies Eyes $1.7 Billion Opportunity After Phase 3 Win

ITCI

Investor's Business Daily

6 months ago

Intra-Cellular Therapies Eyes $1.7 Billion Opportunity After Phase 3 Win

ITCI

MT Newswires

6 months ago

Intra-Cellular Therapies Says Depressive Disorder Therapy Meets Primary, Secondary Endpoints in Second Late-Stage Study

Intra-Cellular depression drug succeeds in second late-stage study

ITCI

BioPharma Dive

6 months ago

Intra-Cellular depression drug succeeds in second late-stage study

Intra-Cellular Therapies Announces Positive Topline Results in Second Phase 3 Trial Evaluating Lumateperone as Adjunctive Therapy in Patients with Major Depressive Disorder

ITCI

GlobeNewswire

6 months ago

Intra-Cellular Therapies Announces Positive Topline Results in Second Phase 3 Trial Evaluating Lumateperone as Adjunctive Therapy in Patients with Major Depressive Disorder

Intra-Cellular Therapies to Present at the 45th Annual Goldman Sachs Global Healthcare Conference

ITCI

GlobeNewswire

7 months ago

Intra-Cellular Therapies to Present at the 45th Annual Goldman Sachs Global Healthcare Conference

Italian energy company targets Britain for fleet of 20 mini-nukes

ITCI

The Telegraph

7 months ago

Italian energy company targets Britain for fleet of 20 mini-nukes

4 Reasons to Buy Invesco QQQ Trust Like There's No Tomorrow

ITCI

Motley Fool

7 months ago

4 Reasons to Buy Invesco QQQ Trust Like There's No Tomorrow

Seoul resumes loudspeaker propaganda against North

ITCI

AFP

7 months ago

Seoul resumes loudspeaker propaganda against North

Barnes Group's (NYSE:B three-year decrease in earnings delivers investors with a 29% loss

ITCI

Simply Wall St.

7 months ago

Barnes Group's (NYSE:B three-year decrease in earnings delivers investors with a 29% loss

American Software Full Year 2024 Earnings: EPS Beats Expectations

ITCI

Simply Wall St.

7 months ago

American Software Full Year 2024 Earnings: EPS Beats Expectations

Harley-Davidson (NYSE:HOG) Hasn't Managed To Accelerate Its Returns

ITCI

Simply Wall St.

7 months ago

Harley-Davidson (NYSE:HOG) Hasn't Managed To Accelerate Its Returns

Best Buy First Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag

ITCI

Simply Wall St.

7 months ago

Best Buy First Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag

3 Mistakes That Can Get Your Costco Membership Canceled

ITCI

Motley Fool

7 months ago

3 Mistakes That Can Get Your Costco Membership Canceled

ITCI

Zacks

7 months ago

Why Is Intra-Cellular (ITCI) Up 1.2% Since Last Earnings Report?

Intra-Cellular Therapies to Present at the Jefferies Global Healthcare Conference

ITCI

GlobeNewswire

7 months ago

Intra-Cellular Therapies to Present at the Jefferies Global Healthcare Conference

ITCI

Insider Monkey

7 months ago

Hedge Funds Like Intra-Cellular Therapies (NASDAQ:ITCI)

Intra-Cellular Therapies Highlights Data Presentations at the American Society of Clinical Psychopharmacology Annual Meeting

ITCI

GlobeNewswire

7 months ago

Intra-Cellular Therapies Highlights Data Presentations at the American Society of Clinical Psychopharmacology Annual Meeting

ITCI

Simply Wall St.

8 months ago

Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) Just Released Its First-Quarter Earnings: Here's What Analysts Think

ITCI

Insider Monkey

8 months ago

Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) Q1 2024 Earnings Call Transcript

Intra-Cellular Therapies to Participate in Two Upcoming Investor Conferences

ITCI

GlobeNewswire

8 months ago

Intra-Cellular Therapies to Participate in Two Upcoming Investor Conferences

ITCI

GuruFocus.com

8 months ago

Intra-Cellular Therapies Inc (ITCI) Q1 2024 Earnings Call Transcript Highlights: Robust Revenue ...

ITCI

MT Newswires

8 months ago

Sector Update: Health Care Stocks Steady Pre-Bell Tuesday

ITCI

GuruFocus.com

8 months ago

Intra-Cellular Therapies Surpasses Q1 Revenue Estimates with Strong CAPLYTA Sales

ITCI

Zacks

8 months ago

Intra-Cellular Therapies (ITCI) Reports Q1 Loss, Tops Revenue Estimates

ITCI

MT Newswires

8 months ago

Intra-Cellular Therapies' Q1 Net Loss Narrows, Net Total Revenue Rises

ITCI

Associated Press Finance

8 months ago

Intra-Cellular: Q1 Earnings Snapshot

Intra-Cellular Therapies Reports First Quarter 2024 Financial Results

ITCI

GlobeNewswire

8 months ago

Intra-Cellular Therapies Reports First Quarter 2024 Financial Results

Acadia Pharmaceuticals (ACAD) Earnings Expected to Grow: Should You Buy?

ITCI

Zacks

8 months ago

Acadia Pharmaceuticals (ACAD) Earnings Expected to Grow: Should You Buy?

Intra-Cellular Therapies to Host First Quarter 2024 Financial Results Conference Call and Webcast

ITCI

GlobeNewswire

8 months ago

Intra-Cellular Therapies to Host First Quarter 2024 Financial Results Conference Call and Webcast

ITCI

Zacks

8 months ago

Will Intra-Cellular Therapies (ITCI) Report Negative Q1 Earnings? What You Should Know

Intra-Cellular Therapies Announces Closing of $575 Million Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

ITCI

GlobeNewswire

8 months ago

Intra-Cellular Therapies Announces Closing of $575 Million Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

ITCI

Insider Monkey

8 months ago

Latest Intra-Cellular Therapies Inc. (ITCI) News on December 27, 2024

Share on Social Networks: